Some drug manufacturers offer patient assistance programs (PAPs) for individuals who meet specific income and insurance criteria
When you drop below it, compensatory mechanisms kick in: increased hunger signals, reduced energy expenditure, stronger cravings for calorie-dense foods
According to the American Heart Association, obesity is one of the leading risk factors for underlying health conditions like diabetes, high blood pressure and heart disease
Because compounded products are customized for individual patients, they do not carry the same regulatory status or the same level of premarket evidence as branded products
That's when the endocrinologist suggested a GLP-1 medication, since the class of drugs had shown promise for treating PCOS, especially the insulin resistance that often comes with the condition and can lead to type 2 diabetes
No, semaglutide does not cause malabsorption